The District of Massachusetts denied Biocon Ltd. and Bicara Therapeutics Inc.'s motion to dismiss Y-Trap Inc.'s action for correction of inventorship of its patent that relates to novel fusion proteins for cancer immunotherapy. The court said that the amended complaint is sufficient at this early stage of litigation.
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.